Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Change in Account Payables (2016 - 2025)

Editas Medicine (EDIT) has disclosed Change in Account Payables for 11 consecutive years, with -$3.6 million as the latest value for Q3 2025.

  • Quarterly Change in Account Payables fell 183.97% to -$3.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$9.3 million through Sep 2025, down 540.25% year-over-year, with the annual reading at -$2.3 million for FY2024, 53.22% down from the prior year.
  • Change in Account Payables for Q3 2025 was -$3.6 million at Editas Medicine, down from $1.3 million in the prior quarter.
  • The five-year high for Change in Account Payables was $7.4 million in Q2 2024, with the low at -$7.0 million in Q4 2024.
  • Average Change in Account Payables over 5 years is -$151526.3, with a median of -$229000.0 recorded in 2022.
  • The sharpest move saw Change in Account Payables crashed 196.29% in 2023, then skyrocketed 1161.95% in 2024.
  • Over 5 years, Change in Account Payables stood at $1.8 million in 2021, then skyrocketed by 46.49% to $2.7 million in 2022, then plummeted by 196.29% to -$2.6 million in 2023, then tumbled by 169.81% to -$7.0 million in 2024, then skyrocketed by 49.12% to -$3.6 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$3.6 million, $1.3 million, and -$27000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.